Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 17 results for "Novartis Company"

Novartis India#39;s board meeting held on November 10, 2017
Money Control

Novartis India#39;s board meeting held on November 10, 2017

We would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 10, 2017. Money Control, 1 month ago
Novartis India Q2 net up 18% at Rs 26 crore Business Standard, 1 week ago

1 images for "Novartis Company"

MSN India, 2 months ago
Rediff.com

After 15 years, Ranjit Shahani steps down as Novartis' India chief

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in Hyderabad Ranjit Shahani is stepping down as managing director of Novartis India after 15 years at the helm. Shahani has been the face of multinational drug firms in India and a champion of causes such as protection of intellectual property rights.   He oversaw the Swiss pharmaceutical giant’s ...
 Rediff.com1 week ago Novartis puts Indian doctor from Harvard in charge as CEO  MSN India2 months ago Novartis names drugs chief as CEO to deliver return to growth  Business Standard2 months ago Novartis names Indian-origin Vas Narasimhan as Global CEO  Money Control2 months ago
Rediff.com

What exactly is wrong with India's pharma companies?

Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation. The number of class action lawsuits filed against Indian pharmaceutical companies has gone up in recent times with US law firms alleging non-disclosure of investor-sensitive information and pay-for-delay conspiracies among other violations by these companies. Six drug companies or subsidiaries of the parent generic drug firms from India have been named in over a dozen class action lawsuits for alleged ...
 Rediff.com2 months ago
Money Control

US states to expand generic drug price-fixing suit - sources

Forty-six US state attorneys general will seek to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG#39;s generic unit Sandoz and India-based Sun Pharmaceutical Industries Ltd.
 Money Control3 weeks ago Mylan top executive engulfed in alleged price-fixing ring  The Financial Chronicle3 weeks ago U.S. states move to expand generic drug price-fixing lawsuit  Reuters3 weeks ago
Rediff.com

100% placements for IIM-Lucknow graduates

Irrespective of demonetisation and GST blues, IIM Lucknow has been able to successfully place their batch of 459 students. Even as the domestic economy battles demonetisation and Goods and Services Tax (GST) blues, the Indian Institute of Management, Lucknow (IIM-L) has bucked the current slowdown blip to clock 100 per cent summer placements. IIM-L has successfully placed its 33rd batch comprising 459 students with the campus witnessing the participation of over 150 domestic and international ...
 Rediff.com1 month ago

Mylan surges, Teva slumps after FDA approves Copaxone copy

By Michael Erman and Divya Grover REUTERS - Mylan NV's long-awaited U.S. approval for its generic version of rival Teva's blockbuster multiple sclerosis treatment Copaxone drove Mylan's shares up around 18 percent on Wednesday while Teva shares plunged. The ...
 Sify1 month ago

UPDATE 1-European shares open higher after record highs in Asia, Wall Street

* Stoxx 600 rises 0.3 pct * Financial stocks among top gainers * Insurance sector still up after Monday rally(Adds comments, more sectors) By Julien Ponthus LONDON, Sept 12 (Reuters) - European bourses continued theirrelief rally, opening higher on Tuesday ...
 Sify2 months ago
Rediff.com

Why GSK is changing its strategy after 93 years

Increased price control over branded generic medicines has affected its profitability GlaxoSmithKline (GSK) Pharmaceuticals is scouting for acquisitions in the domestic market for the first time since it started its operations in the country 93 years ago. The change in strategy comes at a time when the government’ increasing price control over branded generic medicines has affected its profitability.   In the last five years, the revenue of the UK-headquartered company recorded a ...
 Rediff.com2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less